	Baseline PET/CT Radiomics and Clinical Indicators for Pretreatment Response Prediction in Unresectable Hepatocellular Carcinoma: Model Development and Internal Validation. Technol Cancer Res Treat Cheng Y, Chen C, Tang Y, Xu Y, Huang J, Mo Q, Xu F, Lin D. PMID: 42842349 [PubMed - indexed for MEDLINE]
	Baseline low-level viremia in HBV-related hepatocellular carcinoma: prognostic significance, risk stratification, and clinical implications. Front Immunol Ma H, Yu L, Liu X, Yan H, Xie Y, Shang Z, Huo G, Shi W, Zhang Z, Yang Z. PMID: 42840955 [PubMed - indexed for MEDLINE]
	The acidic tumor microenvironment in hepatocellular carcinoma: a barrier to adoptive cellular immunotherapy. Front Immunol Xiong J, Mou G, Ze T, Li X, Zhao H. PMID: 42840603 [PubMed - indexed for MEDLINE]
	Decoding the spatial logic of immune evasion in hepatocellular carcinoma: from single-cell profiling to spatial omics. Front Immunol Xi N, Gao S, Dai C. PMID: 42840587 [PubMed - indexed for MEDLINE]
	A novel clinical FIT model predicts prognosis of unresectable hepatocellular carcinoma treated with TACE combined with lenvatinib and PD-1 inhibitors therapy. Front Immunol Liao M, Wang Z, Wang X, Ai X, Song L, Song Y, Qin W, Wang K, Zhou Y, Liu F, Rao H. PMID: 42840156 [PubMed - indexed for MEDLINE]
	Stratifying Cardiovascular Risk in Patients With HCC Receiving Atezolizumab/Bevacizumab: A Comparison of ESC and CARDIOSOR Scores. Liver Int Stefanini B, Rimassa L, Iavarone M, Cabibbo G, Marra F, Vivaldi C, Dalbeni A, Ponziani FR, Palloni A, Lonardi S, Lani L, Federico P, Svegliati-Baroni G, Pressiani T, Ielasi L, Mazzarelli C, De Lorenzo S, Sacco R, Bruccoleri M, Celsa C, Mastro A, Masi G, Auriemma A, Stella L, Toniutto P, Villani R, Deiana C, Ascari S, Marseglia M, Granito A, Piscaglia F, Tovoli F, ARTE Study Group. PMID: 42839680 [PubMed - indexed for MEDLINE]
	ITO-based multi-band metasurface absorber for early detection of hepatic cancer through deep learning. Opt Express Farooq U, Asif Khan H, Murtaza F, Alathbah M, Yang L, Liu N. PMID: 42839429 [PubMed - indexed for MEDLINE]
	Highly sensitive detection of exosomal miR-122 with CRISPR-Dx for precise HCC diagnosis. Anal Chim Acta Xie C, Lv H, Wang Y, Abdukayum A, Li X, Wu P. PMID: 42838687 [PubMed - indexed for MEDLINE]
	Perfusion beyond Margin in Hepatocellular Carcinoma: A Contrast-enhanced US Feature Related to Tumor Invasiveness and Prognosis. Radiology Ding W, Ji R, Pang C, Li J, Liu F, Yu J, Liang P. PMID: 42836755 [PubMed - indexed for MEDLINE]
	Impact of Liver Metastases on Outcomes With Chemotherapy or Immune Checkpoint Inhibitors in Pancreatic Cancer. Immun Inflamm Dis Kjær LK, Theile S, Madsen K, Johansen JS, Holmström MO, Andersen MH, Chen IM. PMID: 42836590 [PubMed - indexed for MEDLINE]
	Hepatocellular Carcinoma in the Eastern World: Screening, Diagnosis, Staging and Treatment. Curr Pharm Des Wu TH, Cheng CH, Wang YC, Hung HC, Lee JC, Lai Y, Wu TJ, Chou HS, Lee CF, Lee WC, Chan KM. PMID: 42836499 [PubMed - indexed for MEDLINE]
	Polymeric Nanomedicines for siRNA Delivery in Hepatocellular Carcinoma: Emerging Therapeutic Strategies, Combination Approaches, and Translational Perspectives. Int J Nanomedicine Thalij KM, You HW, Habeeb M, Ratchagar JV, Khot VS, Gorde PL. PMID: 42836161 [PubMed - indexed for MEDLINE]
	Optimal timing of surgery after conversion therapy for initially unresectable hepatocellular carcinoma: a multicenter study integrating major pathological response and treatment duration. Front Immunol Li S, Li M, Zhu F, Qin Y, Tang W, Yao J, Chen J, Liu L, Liang Z, Wei H, He Y, Wang G, Zhang J, Xiang B. PMID: 42835116 [PubMed - indexed for MEDLINE]
	Development and external validation of an interpretable deep learning model for early immune-related adverse events in hepatocellular carcinoma. Front Immunol Pan H, Zhao C, Sun H, Zhao H, Tang G, Du X, Xia T. PMID: 42835027 [PubMed - indexed for MEDLINE]
	Direct-Acting Antiviral Therapy in Patients With Hepatocellular Carcinoma Receiving Non-Curative Treatment: High Sustained Virological Response Rates and Preservation of Liver Functional Reserve. J Viral Hepat Sato S, Yamaguchi M, Nago H, Kato Y, Om R, Terai Y, Kita Y, Ikeda Y, Sato S, Murata A, Shimada Y, Genda T. PMID: 42834589 [PubMed - indexed for MEDLINE]
	Efficacy and Safety of First-Line Treatment Options for Oncogene Wild-Type Lung Adenocarcinoma With Liver Metastases. Cancer Med Li J, Ge Y, Liu Q, Wei X, Wang J, Wang X, Wang D, Liu J, Sun Y, Gao A. PMID: 42834503 [PubMed - indexed for MEDLINE]
	Multimodal radiopathomics model predicts postoperative metachronous liver metastasis in gastric cancer. Nat Commun Ding P, Yang J, Guo H, Chen S, Liu Y, Han X, Li S, Wu J, Yang L, Wu H, Meng N, Li X, Gu R, Tian Y, Zhang L, Guo Z, Lu L, Yang S, Meng L, Zhao Q. PMID: 42834048 [PubMed - indexed for MEDLINE]
	H19 and the PD-1/PD-L1 Axis in hepatocellular carcinoma and colorectal cancer: emerging evidence, mechanistic links, and therapeutic perspectives. Clin Exp Med Nami MT, EmamiPari F, Farrokhi N, Fattahyan I, Yekkalam M. PMID: 42831944 [PubMed - indexed for MEDLINE]
	Clinical Presentation and Surgical Management of Liver Hemangioma: A Single-center Retrospective-prospective Study of 101 Cases. Prague Med Rep Nikolaev E, Vylcheva M, Kostov D. PMID: 42831603 [PubMed - indexed for MEDLINE]
	Deep learning-based CNN method for fiducial marker detection in kilovoltage X-ray images for liver tumor motion monitoring. Med Phys Kan F, Jin F, Mylonas A, Zwan B, Nguyen T, Moodie T, Hardcastle N, Liu SF, Mason D, Wang T, Lee YY, Keall P, Sengupta C. PMID: 42830534 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 77732

Page 1 of 3887



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy